Oluf Andersen

8.6k total citations
135 papers, 5.9k citations indexed

About

Oluf Andersen is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Oluf Andersen has authored 135 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pathology and Forensic Medicine, 41 papers in Neurology and 33 papers in Molecular Biology. Recurrent topics in Oluf Andersen's work include Multiple Sclerosis Research Studies (71 papers), Peripheral Neuropathies and Disorders (22 papers) and Polyomavirus and related diseases (16 papers). Oluf Andersen is often cited by papers focused on Multiple Sclerosis Research Studies (71 papers), Peripheral Neuropathies and Disorders (22 papers) and Polyomavirus and related diseases (16 papers). Oluf Andersen collaborates with scholars based in Sweden, United States and United Kingdom. Oluf Andersen's co-authors include Björn Runmarker, Jan Lycke, Lars Rosengren, B. Runmarker, Sara Haghighi, Anders Svenningsson, Anders Oldfors, Philip N. Hawkins, Lars Steen and Mark B. Pepys and has published in prestigious journals such as The Lancet, Brain and Neurology.

In The Last Decade

Oluf Andersen

133 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oluf Andersen Sweden 39 2.6k 2.0k 1.5k 912 860 135 5.9k
Neil Scolding United Kingdom 52 2.4k 0.9× 2.2k 1.1× 1.7k 1.2× 897 1.0× 1.3k 1.5× 218 7.9k
Christian A. Vedeler Norway 38 1.6k 0.6× 1.4k 0.7× 2.8k 1.9× 521 0.6× 1.0k 1.2× 196 6.1k
Antonio Bertolotto Italy 42 2.7k 1.1× 1.4k 0.7× 936 0.6× 1.0k 1.1× 1.1k 1.3× 217 5.7k
Jeremy Chataway United Kingdom 39 2.6k 1.0× 1.1k 0.5× 1.1k 0.7× 762 0.8× 767 0.9× 171 5.1k
Michael P. Pender Australia 45 2.7k 1.1× 985 0.5× 723 0.5× 788 0.9× 2.3k 2.7× 154 5.7k
Pamela McCombe Australia 45 922 0.4× 1.3k 0.6× 2.8k 1.9× 538 0.6× 1.5k 1.8× 231 6.5k
David A. Dyment Canada 37 2.3k 0.9× 1.8k 0.9× 354 0.2× 675 0.7× 1.6k 1.8× 129 5.3k
Anthony T. Reder United States 48 4.4k 1.7× 1.5k 0.8× 1.6k 1.1× 1.3k 1.4× 1.8k 2.1× 160 7.3k
Orhun H. Kantarci United States 37 2.7k 1.0× 1.1k 0.6× 1.6k 1.1× 973 1.1× 772 0.9× 133 4.8k
Cristoforo Comi Italy 42 1.9k 0.7× 1.4k 0.7× 2.3k 1.6× 847 0.9× 938 1.1× 205 6.0k

Countries citing papers authored by Oluf Andersen

Since Specialization
Citations

This map shows the geographic impact of Oluf Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oluf Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oluf Andersen more than expected).

Fields of papers citing papers by Oluf Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oluf Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oluf Andersen. The network helps show where Oluf Andersen may publish in the future.

Co-authorship network of co-authors of Oluf Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Oluf Andersen. A scholar is included among the top collaborators of Oluf Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oluf Andersen. Oluf Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biström, Martin, Jonatan Salzer, Pernilla Stridh, et al.. (2023). Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis. Brain. 147(1). 177–185. 13 indexed citations
2.
Andersen, Oluf, Ingemar Ernberg, & Anna Karin Hedström. (2023). Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System. Infection and Drug Resistance. Volume 16. 4599–4620. 16 indexed citations
3.
Kiffin, Roberta, et al.. (2022). Impact of CYBA genotypes on severity and progression of multiple sclerosis. European Journal of Neurology. 29(5). 1457–1464. 3 indexed citations
4.
Wszołek, Zbigniew K., et al.. (2021). Neuroimaging phenotypes of CSF1R‐related leukoencephalopathy: Systematic review, meta‐analysis, and imaging recommendations. Journal of Internal Medicine. 291(3). 269–282. 15 indexed citations
5.
Sundal, Christina, Susana Carmona, Maria Yhr, et al.. (2019). An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids. Acta Neuropathologica Communications. 7(1). 188–188. 22 indexed citations
6.
Lisovskaja, Vera, Jan Lycke, Clas Malmeström, et al.. (2015). Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis. Neuroepidemiology. 45(2). 83–89. 5 indexed citations
7.
Longhi, Sonia, Oluf Andersen, Staffan Nilsson, et al.. (2014). Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production. Journal of Clinical Virology. 61(1). 107–112. 8 indexed citations
8.
Haghighi, Sara, Annika Lekman, Staffan Nilsson, Maria Blomqvist, & Oluf Andersen. (2011). Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis. Acta Neurologica Scandinavica. 125(1). 64–70. 23 indexed citations
9.
Lycke, Jan, Oluf Andersen, Bo Svennerholm, et al.. (2009). Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis. Acta Neurologica Scandinavica. 85(1). 44–54. 1 indexed citations
10.
Lycke, Jan, et al.. (2009). Possible association of HTLV-I infection and dementia. Acta Neurologica Scandinavica. 88(3). 199–203. 3 indexed citations
11.
Suhr, Ole B., Oluf Andersen, Thomas Aronsson, et al.. (2009). Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in Sweden. Amyloid. 16(4). 208–214. 23 indexed citations
12.
Odén, Anders, et al.. (2008). Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurologica Scandinavica. 119(5). 313–320. 37 indexed citations
13.
Olsen, Rikke Katrine Jentoft, S. E. Olpin, Brage Storstein Andresen, et al.. (2007). ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain. 130(8). 2045–2054. 215 indexed citations
14.
Hartelius, Lena, Björn Runmarker, Oluf Andersen, & Lennart Nord. (2000). Temporal Speech Characteristics of Individuals with Multiple Sclerosis and Ataxic Dysarthria: ‘Scanning Speech’ Revisited. Folia Phoniatrica et Logopaedica. 52(5). 228–238. 48 indexed citations
15.
Ahlmén, J, et al.. (1998). Positive effects of tacrolimus in a case of CIDP. Transplantation Proceedings. 30(8). 4194–4194. 38 indexed citations
16.
Lindberg, Christopher, et al.. (1993). Physical Training Effects in Myasthenia Gravis. Archives of Physical Medicine and Rehabilitation. 74(11). 1178–1180. 44 indexed citations
17.
18.
Vrethem, Magnus, Jan Ernerudh, Mabel Cruz, et al.. (1993). Susceptibility to demyelinating polyneuropathy in plasma cell dyscrasia may be influenced by amino acid position 9 of the HLA-DRβ chain. Journal of Neuroimmunology. 43(1-2). 139–144. 13 indexed citations
19.
Fredman, Pam, Jan Lycke, Oluf Andersen, et al.. (1993). Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope. Journal of Neurology. 240(6). 381–387. 25 indexed citations
20.
Larsson, Nils‐Göran, Oluf Andersen, Elisabeth Holme, Anders Oldfors, & Jan Wahlström. (1991). Leber's hereditary optic neuropathy and complex I deficiency in muscle. Annals of Neurology. 30(5). 701–708. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil Scolding Breakdown of academic impact, for papers by Christian A. Vedeler Breakdown of academic impact, for papers by Antonio Bertolotto Breakdown of academic impact, for papers by Jeremy Chataway Breakdown of academic impact, for papers by Michael P. Pender Breakdown of academic impact, for papers by Pamela McCombe Breakdown of academic impact, for papers by David A. Dyment Breakdown of academic impact, for papers by Anthony T. Reder Breakdown of academic impact, for papers by Orhun H. Kantarci Breakdown of academic impact, for papers by Cristoforo Comi
Rankless by CCL
2026